Rifampicin-Resistant Tuberculosis in a Toddler: A Report of a Rare Paediatric Case in Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria
Autor: | S S Edward, P O Obiajunwa, J I Akande |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Pediatrics
medicine.medical_specialty Tuberculosis rifampicin-resistant 030231 tropical medicine Nigeria Case Report Mycobacterium tuberculosis 03 medical and health sciences 0302 clinical medicine Medicine 030212 general & internal medicine Toddler GeneXpert MTB/RIF biology business.industry Isoniazid General Medicine toddler biology.organism_classification medicine.disease Chronic cough Chronic infection tuberculosis Ile‑Ife Nigeria rifampicin‑resistant toddler tuberculosis medicine.symptom business Ile-Ife Rifampicin medicine.drug |
Zdroj: | Nigerian Medical Journal : Journal of the Nigeria Medical Association Nigerian Medical Journal; Vol. 61 No. 5 (2020); 281-283 |
ISSN: | 2229-774X 0300-1652 |
Popis: | The emergence of resistant strains of mycobacterium tuberculosis (TB) to antituberculous drugs has compounded the management of the chronic infection. More than 90% of rifampicin (RIF)‑resistant isolates are also isoniazid resistant; hence, rifampicin resistance (RR) is a surrogate marker for multidrug resistant TB (MDR‑TB). Although there are limited reports of pediatric RR/MDR‑TB in Nigeria, there had not been similar report in our hospital until now. A 2‑year‑old girl was admitted with 2‑month history of fever, cough with dyspnea, and progressive weight loss. There was no known contact with adult who had chronic cough; the toddler and her parents have not been treated for TB in the past. Her chest X‑ray showed nodular opacities, while gastric washout for GeneXpert MTB/RIF confirmed RIF‑resistant TB. The parents declined screening for TB despite counseling. The patient was subsequently referred to a specialized center for the management of drug‑resistant TB, but the parents failed to go for the treatment. Young children are at risk of developing TB disease and MDR/RR‑TB, which is more complex to manage than drug‑susceptible TB due to longer treatment duration, increased toxicity, as well as poor parental compliance to the demand of treatment. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |